ALK CELMoDs

N/A

Report date: 2026/05/20 20:02:01
NME

Base Information

Drug NameALK CELMoDs
Drug Alias Namecereblon-mediated ALK molecular glue degrader (NBristol-Myers Squibb)
ClassificationSmall molecules > Molecular Glue
Mechanisms of ActionCereblon modulatorsAnticancer protein kinase inhibitorsAnaplastic lymphoma kinase inhibitors
TargetsAnaplastic lymphoma kinaseCereblon
Therapy Area/IndicationsCarcinoma, Non-Small-Cell Lung
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBristol-Myers Squibb Company
China Registration ClassN/A

Develop Information

Active CompaniesBristol-Myers Squibb Company
Inactive CompaniesN/A
Active IndicationsCarcinoma, Non-Small-Cell Lung
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A